Frequency of Hyperprolactinemia in Patients with Overt and Subclinincal Hypothyroidism.
Main Article Content
Abstract
Objective: To see the frequency of hyperprolactinemia in patients with subclinical and overt hypothyroidism.
Methodology: This is a descriptive cross-sectional, was performed at the Department of Endocrinology, MTI Lady Reading Hospital, Peshawar, Pakistan. Patients with overt and subclinical hypothyroidism were included in this study. Pregnant or lactating women, patients with a history of renal or hepatic impairment, and patients taking medications that could cause hyperprolactinemia, such as antidepressants, antipsychotics, metoclopramide, and estrogen-containing oral contraceptive pills, were excluded from the study. The frequency of hyperprolactinemia was recorded in these patients.
Results: Among 377 patients who had subclinical or overt hypothyroidism, 140 (37.1%) patients were males, while 237 (62.9%) were females. Two hundred and ninety-five (78.2%) patients had subclinical hypothyroidism, while 82 (21.8%) patients were overtly hypothyroid. Among patients with hyperprolactinemia and subclinical or overt hypothyroidism, 25 (27.2 %) were males and 67 (62.8%) were females (p=0.02). Among patients with hyperprolactinemia, 25 (30.4%) were having hypothyroidism while 67 (22.7%) patients were having subclinical hypothyroidism (p=0.14).
Conclusion: Both subclinical and overt hypothyroidism is pretty prevalent in patients with high prolactin levels, especially in females.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M, et al. Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol 2022;186(3):1-33.
Sheikhi V, Heidari Z. Increase in thyrotropin is associated with an increase in serum prolactin in euthyroid subjects and patients with subclinical hypothyroidism. Med J Islam Repub Iran 2021;35(1):1136-41.
Hekimsoy Z, Kafesciler S, Guclu F, Ozmen B. The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism. Endocr J 2010;57(12):1011-5.
Healy ML, Smith TP, McKenna TJ. Diagnosis, misdiagnosis, and management of hyperprolactinemia. Expert Rev Endocrinol Metab 2006;1(1):123-132.
Sobolewska J, Zak Z, Monia-Tutur K, Wojciechowska-Luzniak A, Witek P, Niemczyk S. Endocrine disorders in chronic kidney disease. Paediatr Fam Med 2022;18(3):209-18.
Frohlich E, Wahl R. The forgotten effects of thyrotropin-releasing hormone: metabolic functions and medical applications. Front Neuroendocrinol 2019;52:29-43.
Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA 2019;322(2):153-60.
Goel P, Narang S, Gupta BK, Goel KP. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism. J Clin Diagn Res 2015;9(1):15-7.
Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur J Intern Med 2016;35:106-10.
Tamrakar R, Rai A, Maskey R. Hyperprolactinemia in subclinical hypothyroid patients at BPKIHS, Dharan. J Nobel Med Coll 2023;12(1):45-9.
Khorassanizadeh R, Sundaresh V, Levine SN. Primary hypothyroidism with exceptionally high prolactin—a really big deal. World Neurosurg 2016;91:675.e11.
Hekimsoy Z, Kafesciler S, Guclu F, Ozmen B. The prevalence of hyperprolactinemia in overt and subclinical hypothyroidism. Endocr J 2010;57(12):1011-5.
Tasneem A, Fatima I, Ali A, Mehmood N, Amin MK. The incidence of hyperprolactinemia and associated hypothyroidism: local experience from Lahore. Pak J Nucl Med 2011;1:49-55.
Sirohi T, Singh H. Estimation of serum prolactin levels and determination of prevalence of hyperprolactinemia in newly diagnosed cases of subclinical hypothyroidism. J Family Med Prim Care 2018;7(6):1279-82.
Gilani MS, Khan DA, Iftikhar G, Khan FA. Spectrum of disorders leading to hyperprolactinemia. Pak Armed Forces Med J 2013;63(1):17-21.
Danicic JM, Inder WJ, Kotowicz MA. Impact of subclinical hypothyroidism on health-related quality of life: a narrative review. Intern Med J 2021;51(9):1380-137.
Tekle HA, Bobe TM, Tufa EG, Solomon FB. Age-sex disparities and sub-clinical hypothyroidism among patients in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia. J Health Popul Nutr. 2018;37(1):1-7.
Mahanta A, Choudhury S, Choudhury SD. Prevalence of hypothyroidism in Assam: a clinic-based observational study. Thyroid Res Pract 2017;14(2):63-70.
Phillipps HR, Yip SH, Grattan DR. Patterns of prolactin secretion. Mol Cell Endocrinol 2020;502.
Sirohi T, Singh H. Estimation of serum prolactin levels and determination of prevalence of hyperprolactinemia in newly diagnosed cases of subclinical hypothyroidism. J Fam Med Prim Care 2018;7(6):1279-82.